Your browser doesn't support javascript.
loading
Pre-existing conditions associated with post-acute sequelae of COVID-19.
Jacobs, Elizabeth T; Catalfamo, Collin J; Colombo, Paulina M; Khan, Sana M; Austhof, Erika; Cordova-Marks, Felina; Ernst, Kacey C; Farland, Leslie V; Pogreba-Brown, Kristen.
Afiliación
  • Jacobs ET; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA. Electronic address: jacobse@email.arizona.edu.
  • Catalfamo CJ; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Colombo PM; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Khan SM; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Austhof E; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Cordova-Marks F; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Ernst KC; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Farland LV; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Pogreba-Brown K; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
J Autoimmun ; 135: 102991, 2023 02.
Article en En | MEDLINE | ID: mdl-36634460
ABSTRACT
Post-acute sequelae of COVID-19 (PASC) are conditions that occur or remain at least 28 days after SARS-CoV-2 infection. While some risk factors for PASC have been identified, little is known about pre-existing conditions that render one susceptible to developing PASC. Data from participants (n = 1224) in a longitudinal COVID-19 cohort study in Arizona were used to investigate comorbid conditions associated with PASC. After adjustment of the models for age, BMI, gender, race, and smoking, the following pre-existing conditions were statistically significantly associated with the development of PASC asthma (OR = 1.54; 95% CI = 1.10-2.15); chronic constipation (OR = 4.29; 95% CI = 1.15-16.00); reflux (OR = 1.54; 95% CI = 1.01-2.34); rheumatoid arthritis (OR = 3.69; 95%CI = 1.15-11.82); seasonal allergies (OR = 1.56; 95% CI = 1.22-1.98); and depression/anxiety (OR = 1.72; 95% CI = 1.17-2.52). When grouping conditions together, statistically significant associations with PASC were observed for respiratory (OR = 1.47; 95% CI = 1.06-2.14); gastrointestinal (OR = 1.62; 95% CI = 1.16-2.26), and autoimmune conditions (OR = 4.38; 95% CI = 1.59-12.06). After adjustment for severity of acute SARS-CoV-2 infection and depression/anxiety, seasonal allergies (OR = 1.48; 95% CI 1.15-1.91) and autoimmune disease (OR = 3.78; 95% CI - 1.31-10.91) remained significantly associated with risk for PASC. These findings indicate that numerous pre-existing conditions may be associated with an increased risk for the development of PASC. Patients with these conditions should consider taking extra steps to avoid infection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Enfermedades Autoinmunes / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Autoimmun Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Enfermedades Autoinmunes / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Autoimmun Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article